Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 12Completed 9Active not recruiting 8Unknown 3Terminated 3Withdrawn 2Not yet recruiting 2No longer available 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Triple Negative Breast Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Squamous Cell Carcinoma of Head and Neck 5Breast Neoplasms 5Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Turcot syndrome 3Neoplasm Metastasis 3Melanoma 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Lung Neoplasms 2Hodgkin Disease 2Glioblastoma 2Endometrial Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Biliary Tract Neoplasms 2Advanced Endometrial Cancer 2Tongue Neoplasms 1To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma 1Thyroid Neoplasms 1Thoracic Neoplasms 1Stomach Neoplasms 1Squamous NSCLC 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Rare Tumour 1

Interventions

Temozolomide 11Radiotherapy 4Magnetic Resonance Spectroscopy 4Specimen Handling 3Radiation 3Blood Specimen Collection 3Bevacizumab 3tislelizumab 2pembrolizumab 2Surgical Procedures, Operative 2mirdametinib 1gallium maltolate 1fluzoparib 1florbetapir 1elemene 1cemiplimab 1X-Rays 1Vortioxetine 1Transurethral Resection of Bladder 1Spironolactone 1Spinal Puncture 1Sitagliptin Phosphate 1Sampling Studies 1Receptors, Interleukin-8B 1Radiotherapy, Intensity-Modulated 1Psychosocial Intervention 1Platinum 1Photons 1Photochemotherapy 1Pharmaceutical Preparations 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Glioblastoma × pembrolizumab × Clear all
NCT07385846 2026-02-04

Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency

University of Cincinnati

Phase 1 Not yet recruiting
8 enrolled
CNS

Turcot syndrome, Glioblastoma

NCT06749925 2025-04-01

Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma

University of Sao Paulo General Hospital

Phase 3 Not yet recruiting
186 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡